Related Experiment Video
Updated: May 4, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Pain management in a patient with renal and hepatic dysfunction
David B Brecher1, Tasheba L West
11 Adult Palliative Medicine Service, Multicare Health System, Tacoma General Hospital , Tacoma, Washington.
Background:
Palliative medicine providers are often consulted to provide guidance for pain relief for a diverse population. End-of-life care is often challenging, balancing optimum pain relief with minimal side effects. Patients with both renal and hepatic dysfunction are particularly challenging when considering appropriate treatments.
Conclusion:
This case discussion highlights an end-of-life pain symptom management challenge, and the associated pharmacological background. Ultimately, with no ideal pharmaceutical option, individualization of therapy will be crucial. Collaboration of palliative medicine providers and pharmacists may concurrently provide the best possible care at the best possible time and in the optimal location.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Urinary Tract Calculi V: Nursing Management
